Placeholder

FACULTY

Matthew Lammi

Associate Professor - Clinical, Clinical Associate Professor

Medicine - Pulmonary/Critical Care Medicine

Academic Office:

LSUHSC School of Medicine 
1901 Perdido Street, MEB 3205
New Orleans, LA 70112

504-568-4634

 

Clinical Office:

University Medical Center
2000 Canal St, 
New Orleans, LA 70112

504-702-5057, phone
504-702-3140, fax

 

Bio

Dr. Lammi is a pulmonary and critical care physician who specializes in the care of patients with pulmonary hypertension (PH) and those with autoimmune-related lung disease, particularly scleroderma. He is the Director of the Pulmonary Hypertension Association (PHA)-accredited Comprehensive Pulmonary Hypertension Center at University Medical Center, which is a collaboration between LSU and Tulane providers. He is actively involved in national committees through the PHA and the American Thoracic Society. He has received external grants from NIGMS, the Department of Defense, and the Scleroderma Foundation for his research program, which is focused on the early detection and treatment of pulmonary hypertension in scleroderma patients. Dr. Lammi is also actively involved in clinical trials, both in PH and scleroderma. Additionally, he is also the Associate Program Director for Research in the Pulmonary and Critical Care fellowship program.   

Education

Undergraduate:
B.A. in Biology
Bucknell University
Lewisburg, Pennsylvania

Medical:
M.D.
Temple University School of Medicine
Philadelphia, Pennsylvania

Internship:
Internal Medicine
Temple University School of Medicine
Philadelphia, Pennsylvania

Residency:
Internal Medicine
Temple University School of Medicine
Philadelphia, Pennsylvania

Chief Residency:
Internal Medicine
Temple University School of Medicine
Philadelphia, Pennsylvania

Fellowship:
Pulmonary and Critical Care
Temple University School of Medicine
Philadelphia, Pennsylvania

Affiliated Hospitals & Clinics

  • University Medical Center
  • Ocshner Baptist Medical Center
  • Ocshner Kenner Medical Center

Publications

1. Lammi MR, Samant S, Tran HV, Uddo RB, Saketkoo LA, Saito S, Helmcke FR, deBoisblanc BP, "Jugular venous ultrasound predicts outcomes in pulmonary hypertension outpatients".Eur Respir J. 2022 Jan 27;59(1):2102591. doi: 10.1183/13993003.02591-2021. Print 2022 Jan.

2. Minhas J, Narasimmal SP, M Bull T, Marco T, McConnell JW, Lammi MR, Thenappan T, P Feldman J, S Sager J, B Badesch D, Ryan JJ, C Grinnan D, Zwicke D, M Horn E, Elwing JM, Moss JE, Eggert M, Shlobin OA, P Frantz R, D Bartolome S, Mathai SC, Mazimba S, C Pugliese S, Al-Naamani N, "Health-related quality of life and hospitalizations in chronic theomboembolic pulmonary hyptertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)".Pulm Circ. 2021 Oct 14;11(4):20458940211053196. doi: 10.1177/20458940211053196. eCollection 2021 Oct-Dec.

3. Saketkoo LA, Frech T, Varjú C, Domsic R, Farrell J, Gordon JK, Mihai C, Sandorfi N, Shapiro L, Poole J, Volkmann ER, Lammi M, McAnally K, Alexanderson H, Pettersson H, Hant F, Kuwana M, Shah AA, Smith V, Hsu V, Kowal-Bielecka O, Assassi S, Cutolo M, Kayser C, Shanmugam VK, Vonk MC, Fligelstone K, Baldwin N, Connolly K, Ronnow A, Toth B, Suave M, Farrington S, Bernstein EJ, Crofford LJ, Czirják L, Jensen K, Hinchclif M, Hudson M, Lammi MR, Mansour J, Morgan ND, Mendoza F, Nikpour M, Pauling J, Riemekasten G, Russell AM, Scholand MB, Seigart E, Rodriguez-Reyna TS, Hummers L, Walker U, Steen V. A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc. Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101707. doi: 10.1016/j.berh.2021.101707. Epub 2021 Sep 15. PMID: 34538573; PMCID: PMC8670736.

4. Pettersson H, Alexanderson H, Poole JL, Varga J, Regardt M, Russell AM, Salam Y, Jensen K, Mansour J, Frech T, Feghali-Bostwick C, Varjú C, Baldwin N, Heenan M, Fligelstone K, Holmner M, Lammi MR, Scholand MB, Shapiro L, Volkmann ER, Saketkoo LA. Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101695. doi: 10.1016/j.berh.2021.101695. Epub 2021 Jul 1. PMID: 34217607; PMCID: PMC8478716.

5. Samant S, Tran HV, Uddo RB, deBoisblanc BP, Saketkoo LA, Saito S, Helmcke FR, Lammi MR. Use of Handheld Ultrasound to Estimate Right Atrial Pressure in a Pulmonary Hypertension Clinic. Ann Am Thorac Soc. 2022 Feb;19(2):179-185. doi: 10.1513/AnnalsATS.202101-092OC. PMID: 34214012.

6. Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel). 2021 Jun 15;11(6):1089. doi: 10.3390/diagnostics11061089. PMID: 34203584; PMCID: PMC8232334.

7. DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2021 May 17;11(3):20458940211020913. doi: 10.1177/20458940211020913. PMID: 34158918; PMCID: PMC8186121.

8. Mathews KS, Seitz KP, Vranas KC, Duggal A, Valley TS, Zhao B, Gundel S, Harhay MO, Chang SY, Hough CL; National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network. Variation in Initial U.S. Hospital Responses to the Coronavirus Disease 2019 Pandemic. Crit Care Med. 2021 Jul 1;49(7):1038-1048. doi: 10.1097/CCM.0000000000005013. PMID: 33826584; PMCID: PMC8217146.

9. Lammi MR, Ghonim MA, Johnson J, D'Aquin J, Zamjahn JB, Pellett A, Okpechi SC, Romaine C, Pyakurel K, Luu HH, Shellito JE, Boulares AH, deBoisblanc BP. Acute effect of inhaled iloprost on exercise dynamic hyperinflation in COPD patients: A randomized crossover study. Respir Med. 2021 Apr-May;180:106354. doi: 10.1016/j.rmed.2021.106354. Epub 2021 Mar 8. PMID: 33721696; PMCID: PMC8425068.

10. Kolaitis NA, Zamanian RT, de Jesus Perez VA, Badesch DB, Benza RL, Burger CD, Chakinala MM, Elwing JM, Feldman J, Lammi MR, Mathai SC, McConnell JW, Presberg KW, Robinson JC, Sager J, Shlobin OA, Simon MA, Kawut SM, Glidden DV, Singer JP, De Marco T; Pulmonary Hypertension Association Registry Investigators. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry. Ann Am Thorac Soc. 2021 Apr;18(4):613-622. doi: 10.1513/AnnalsATS.202007-774OC. PMID: 33064950; PMCID: PMC8174020.